| 3KY Stock | | | EUR 2.14 0.02 0.93% |
CEO
Huijuan Zhong is Chief Executive Officer, Executive Chairlady of the Board of HANSOH PHARMAC HD 00001 since 2018.
| Age | 58 |
| Tenure | 6 years |
| Phone | 86 21 3177 3517 |
| Web | http://www.hspharm.com |
HANSOH PHARMAC Management Efficiency
The company has return on total asset
(ROA) of
0.063 % which means that it generated a profit of $0.063 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.1366 %, meaning that it generated $0.1366 on every $100 dollars invested by stockholders. HANSOH PHARMAC's management efficiency ratios could be used to measure how well HANSOH PHARMAC manages its routine affairs as well as how well it operates its assets and liabilities.
HANSOH PHARMAC HD 00001 has accumulated 92.75
M in total debt with debt to equity ratio
(D/E) of 0.01, which may suggest the company is not taking enough advantage from borrowing. HANSOH PHARMAC HD has a current ratio of 6.3, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist HANSOH PHARMAC until it has trouble settling it off, either with new capital or with free cash flow. So, HANSOH PHARMAC's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like HANSOH PHARMAC HD sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for HANSOH to invest in growth at high rates of return. When we think about HANSOH PHARMAC's use of debt, we should always consider it together with cash and equity.
Similar Executives
Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals and active pharmaceutical ingredients in the Peoples Republic of China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd. HANSOH PHARMAC operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 11645 people. HANSOH PHARMAC HD 00001 (3KY) is traded on Frankfurt Exchange in Germany and employs 10,783 people.
Management Performance
HANSOH PHARMAC HD Leadership Team
Elected by the shareholders, the HANSOH PHARMAC's board of directors comprises two types of representatives: HANSOH PHARMAC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HANSOH. The board's role is to monitor HANSOH PHARMAC's management team and ensure that shareholders' interests are well served. HANSOH PHARMAC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HANSOH PHARMAC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Min Hu, Vice President | |
| Shengli Zhong, Vice President Joint Company Secretary | |
| Huijuan Zhong, Chief Executive Officer, Executive Chairlady of the Board | |
| Chuanhe Xu, Senior Vice President | |
| Sheung Chan, Non-Executive Independent Director | |
| Rudi Bao, Senior Vice President | |
| Chunhua Zhong, Senior Vice President | |
| Guoqiang Lin, Non-Executive Independent Director | |
| Dongtao Yang, Non-Executive Independent Director | |
| Yuan Sun, Executive Director | |
| Cuifang Ma, Non-Executive Director | |
| Gongzheng Wu, Senior Vice President | |
| Aifeng Lyu, Executive Director | |
| Yan Li, Joint company secretary | |
HANSOH Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is HANSOH PHARMAC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in HANSOH Stock
HANSOH PHARMAC financial ratios help investors to determine whether HANSOH Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HANSOH with respect to the benefits of owning HANSOH PHARMAC security.